Vanguard Portfolio Management
RCKT icon

Vanguard Portfolio Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Vanguard Portfolio Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9M Buy
5,810,033
+1,119,818
+24% +$3.72M ﹤0.01% 2003
2026
Q1 		$16.8M Buy
+4,690,215
New +$18.6M ﹤0.01% 1962

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Portfolio Management's RCKT Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Rocket Pharmaceuticals (RCKT) stake by 24% in Q2 2026, buying an estimated $3.72M and bringing the position to 5,810,033 shares worth $19.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Vanguard Portfolio Management first reported a position in RCKT in Q1 2026 and has held it in 2 quarters since. 176 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Vanguard Portfolio Management held 5,810,033 shares of Rocket Pharmaceuticals worth $19.9M as of Q2 2026.
  • Vanguard Portfolio Management bought 1,119,818 Rocket Pharmaceuticals shares in Q2 2026, an estimated $3.72M.
  • Rocket Pharmaceuticals made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2003 holding.
  • Vanguard Portfolio Management first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 176 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.